271 related articles for article (PubMed ID: 23298620)
41. Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.
Kadlub N; Sessiecq Q; Dainese L; Joly A; Lehalle D; Marlin S; Badoual C; Galmiche L; Majoufre-Lefebvre C; Berdal A; Deckert M; Vazquez MP; Descroix V; Coudert AE; Picard A
Hum Pathol; 2016 Dec; 58():62-71. PubMed ID: 27498064
[TBL] [Abstract][Full Text] [Related]
42. [Gene mutation and expression of SH-3BP-2 in cherubism].
Li YW; Meng XM; Yu SF; Gao P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
[TBL] [Abstract][Full Text] [Related]
43. [Genetic aspects of cherubism].
Brix M; Peters H; Ranfaing E; Ricbourg B
Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
[TBL] [Abstract][Full Text] [Related]
44. Cherubism. A case report.
Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
[TBL] [Abstract][Full Text] [Related]
45. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
46. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
[TBL] [Abstract][Full Text] [Related]
47. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
[TBL] [Abstract][Full Text] [Related]
48. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
Deckert M; Prod'Homme V
Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
[No Abstract] [Full Text] [Related]
49. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
[TBL] [Abstract][Full Text] [Related]
50. Cherubism--a case report with long term follow up.
Chavali LV; Bhimalingam RM; Sudhakar PV
Indian J Pathol Microbiol; 2011; 54(4):793-5. PubMed ID: 22234113
[TBL] [Abstract][Full Text] [Related]
51. [Clinicopathologic analysis and genetic investigation of two families with cherubism].
Wang CN; Song YL; Jiang Y; Lu DH; Bian Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):416-9. PubMed ID: 17067459
[TBL] [Abstract][Full Text] [Related]
52. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
53. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
[TBL] [Abstract][Full Text] [Related]
54. Cherubism--clinical picture and treatment.
Kozakiewicz M; Perczynska-Partyka W; Kobos J
Oral Dis; 2001 Mar; 7(2):123-30. PubMed ID: 11355438
[TBL] [Abstract][Full Text] [Related]
55. [Molecular and Cellular Pathogenesis of Cherubism].
Ueki Y
Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
[TBL] [Abstract][Full Text] [Related]
56. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
[TBL] [Abstract][Full Text] [Related]
57. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
[TBL] [Abstract][Full Text] [Related]
58. A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib.
Ricalde P; Ahson I; Schaefer ST
J Oral Maxillofac Surg; 2019 Jun; 77(6):1278.e1-1278.e7. PubMed ID: 30880133
[TBL] [Abstract][Full Text] [Related]
59. Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature.
Ozkan Y; Varol A; Turker N; Aksakalli N; Basa S
Int J Pediatr Otorhinolaryngol; 2003 Sep; 67(9):1005-12. PubMed ID: 12907058
[TBL] [Abstract][Full Text] [Related]
60. [Cherubism: diagnosis and treatment in the pediatric age].
Sánchez Burgos R; Martín Pérez M; Ramírez Piqueras M; Gómez García E; Burgueño García M
Cir Pediatr; 2012 Jan; 25(1):56-9. PubMed ID: 23113415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
